GSK receives FDA approval for oral antibiotic to treat UTIs
Tweet
Share
E-mail
Get Alerts GSK Hot Sheet
Join SI Premium – FREE
The U.S. Food and Drug Administration has approved GSK's (NYSE: GSK) oral antibiotic for the treatment of complicated urinary tract infections, according to a statement from the regulator.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- U.S. and Denmark close in on a Greenland deal - Reuters
- Fold Holdings (FLD) files for 51.23M share offering by selling stockholders
- Thrive Capital distributes 6.3M Oscar Health shares to limited partners
Create E-mail Alert Related Categories
Corporate News, FDARelated Entities
Maynard Um, Mark Zuckerberg, FDA, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
